 |
 |
 |
| 24小時(shí)熱門版塊排行榜 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 5 | 1/1 | 返回列表 |
| 查看: 645 | 回復(fù): 4 | |||
| 【獎(jiǎng)勵(lì)】 本帖被評(píng)價(jià)4次，作者fishhope增加金幣 3.2 個(gè) | |||
[資源]
《化學(xué)前沿》2012年4月（英文版）-THOMSON REUTERS
|
|||
|
IN THIS ISSUE 1 ORGA NIC SYNTHESIS SCHEME SHOWCASE In this report, we look at a breakthrough chemoenzymatic approach that shows promise for a more efficient route to synthesize ultra low molecular weight heparins. 4 SCAFFOLDS ON THE MOVE Dihydronaphthyridinediones could represent a novel structural class of potent and selective phosphodiesterase PDE7 inhibitors for the treatment of cognitive disorders. Also showcased are antimalarial agents, oncolytic drugs, and drugs to combat HIV. 8 NEW MOLECULAR MECHANISMS OF ACTION Hydroxyacid oxidase 2 (HAOX2, HAO2) inhibitors, integrin alphaMbeta2 (MAC-1) agonists and histone acetyltransferase (HAT) activators, among a range of fascinating compounds, are showcased in this issue. 9 THE START ING LINE A selection of new molecular entities ready to progress in the R&D arena including pharmacological activity, originator, and chemical structure. 12 NEW DRUGS FOR OLD The search for new drugs is an increasingly costly business. With patents expiring and pipelines drying up it is possible that the pharmaceutical industry is truly at the end of the so-called era of blockbusters. In this article, we look at how the industry is finding ways to reformulate and repurpose old products to new diseases and extracting novel applications for known agents. |
回復(fù)此樓» 本帖附件資源列表
-
歡迎監(jiān)督和反饋：小木蟲僅提供交流平臺(tái)，不對(duì)該內(nèi)容負(fù)責(zé)。
本內(nèi)容由用戶自主發(fā)布，如果其內(nèi)容涉及到知識(shí)產(chǎn)權(quán)問(wèn)題，其責(zé)任在于用戶本人，如對(duì)版權(quán)有異議，請(qǐng)聯(lián)系郵箱：xiaomuchong@tal.com - 附件 1 : CuttingEdgeOfChemistry-2012-April.pdf
2014-02-27 07:52:23, 406.16 K
» 收錄本帖的淘帖專輯推薦
 信息調(diào)研 |
» 猜你喜歡
求助�。�！大佬救命�。。�
已經(jīng)有4人回復(fù)
-
酰胺縮合
已經(jīng)有3人回復(fù)
-
藥理學(xué)論文潤(rùn)色/翻譯怎么收費(fèi)?
已經(jīng)有216人回復(fù)
-
藥學(xué)專碩調(diào)劑
已經(jīng)有2人回復(fù)
-
藥學(xué)學(xué)碩326求調(diào)劑
已經(jīng)有1人回復(fù)
-
105500藥學(xué)調(diào)劑，一志愿頂9，主持省級(jí)大創(chuàng)，實(shí)驗(yàn)型SCI二作，四六級(jí)已過(guò)，雙國(guó)獎(jiǎng)
已經(jīng)有6人回復(fù)
-
藥學(xué)專碩調(diào)劑
已經(jīng)有0人回復(fù)
-
publcif的使用
已經(jīng)有0人回復(fù)
-
求調(diào)劑
已經(jīng)有2人回復(fù)
-
會(huì)計(jì)專碩求調(diào)劑
已經(jīng)有0人回復(fù)
-
新加坡國(guó)立大學(xué)藥學(xué)系化學(xué)生物學(xué)課題組招PhD
已經(jīng)有12人回復(fù)
» 本主題相關(guān)價(jià)值貼推薦，對(duì)您同樣有幫助:
- 【軟件】Thomson Reuters EndNote X7 for Mac
已經(jīng)有139人回復(fù)
- 【軟件】Thomson Reuters EndNote X7 17.0.2.7390 參考文獻(xiàn)管理軟件
已經(jīng)有306人回復(fù)
- 2013第三季度藥業(yè)新觀察（Thomson Reuters）以及2013年1-3季度的仿制藥發(fā)展動(dòng)態(tài)
已經(jīng)有72人回復(fù)
- 請(qǐng)問(wèn)thomson reuters 和SCI到底什么關(guān)系？這個(gè)雜志被SCI收錄了嗎？
已經(jīng)有9人回復(fù)
- *** journal have been tracked for Impact Factors by Thomson Reuters(ISI)
已經(jīng)有7人回復(fù)
1949stone
榮譽(yù)版主 (知名作家)
- 應(yīng)助: 95 (初中生)
- 貴賓: 2.38
- 金幣: 2627.9
- 帖子: 9830
- 在線: 2692.8小時(shí)
- 蟲號(hào): 765987
2樓2014-02-27 08:24:36
簡(jiǎn)單回復(fù)
2014-02-27 08:33
回復(fù)
五星好評(píng) 頂一下，感謝分享！
kuanghua4樓
2014-03-01 08:54
回復(fù)
五星好評(píng) 頂一下，感謝分享！
200025045樓
2015-07-29 12:48
回復(fù)
五星好評(píng) 頂一下，感謝分享！
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 fishhope 的主題更新
| 5 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
50